Catalent Inc (CTLT)
59.66
+0.66
(+1.12%)
USD |
NYSE |
Nov 21, 16:00
59.66
0.00 (0.00%)
After-Hours: 20:00
Catalent Revenue (Quarterly): 1.023B for Sept. 30, 2024
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 1.023B |
| June 30, 2024 | 1.301B |
| March 31, 2024 | 1.074B |
| December 31, 2023 | 1.024B |
| September 30, 2023 | 982.00M |
| June 30, 2023 | 1.055B |
| March 31, 2023 | 1.037B |
| December 31, 2022 | 1.149B |
| September 30, 2022 | 1.022B |
| June 30, 2022 | 1.287B |
| March 31, 2022 | 1.273B |
| December 31, 2021 | 1.217B |
| September 30, 2021 | 1.025B |
| June 30, 2021 | 1.188B |
| March 31, 2021 | 1.053B |
| December 31, 2020 | 911.00M |
| September 30, 2020 | 846.00M |
| June 30, 2020 | 947.30M |
| March 31, 2020 | 760.60M |
| December 31, 2019 | 721.40M |
| September 30, 2019 | 664.70M |
| June 30, 2019 | 725.70M |
| March 31, 2019 | 617.50M |
| December 31, 2018 | 623.00M |
| September 30, 2018 | 551.80M |
| Date | Value |
|---|---|
| June 30, 2018 | 685.30M |
| March 31, 2018 | 627.90M |
| December 31, 2017 | 606.30M |
| September 30, 2017 | 543.90M |
| June 30, 2017 | 616.90M |
| March 31, 2017 | 532.60M |
| December 31, 2016 | 483.70M |
| September 30, 2016 | 442.20M |
| June 30, 2016 | 532.20M |
| March 31, 2016 | 438.00M |
| December 31, 2015 | 454.90M |
| September 30, 2015 | 423.00M |
| June 30, 2015 | 510.10M |
| March 31, 2015 | 446.60M |
| December 31, 2014 | 455.80M |
| September 30, 2014 | 418.30M |
| June 30, 2014 | 519.60M |
| March 31, 2014 | 453.10M |
| December 31, 2013 | 440.70M |
| September 30, 2013 | 414.30M |
| June 30, 2013 | 505.20M |
| March 31, 2013 | 447.00M |
| December 31, 2012 | 436.10M |
| September 30, 2012 | 412.00M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
721.40M
Minimum
Dec 2019
1.301B
Maximum
Jun 2024
1.045B
Average
1.031B
Median
Revenue (Quarterly) Benchmarks
| Eli Lilly and Co | 11.44B |
| Boston Scientific Corp | 4.209B |
| Pfizer Inc | 17.70B |
| Merck & Co Inc | 16.66B |
| BioCardia Inc | -- |
Revenue (Quarterly) Related Metrics
| Net Income (Quarterly) | -129.00M |
| Total Expenses (Quarterly) | 1.107B |
| EPS Diluted (Quarterly) | -0.71 |
| Enterprise Value | 15.43B |
| Gross Profit Margin (Quarterly) | 17.69% |
| Profit Margin (Quarterly) | -12.61% |
| Earnings Yield | -3.80% |
| Normalized Earnings Yield | -3.955 |